Patents Represented by Attorney Lisa M. Hemmindinger
  • Patent number: 6844168
    Abstract: A new receptor for fibroblast growth factor has been cloned and expressed. The recombinant receptor is useful for inhibiting FGF activity, and for screening compounds for binding activity similar to that of FGF. A soluble, truncated recombinant receptor is also prepared, and is capable of binding FGF.
    Type: Grant
    Filed: July 20, 2000
    Date of Patent: January 18, 2005
    Assignee: Chiron Corporation
    Inventors: Michael C. Keifer, Pablo D. T. Valenzuela, Philip J. Barr